As the world’s leading organization dedicated to transforming lung cancer survivorship, GO2 is dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. The Global Advisory Council (GAC) is a vital extension of this mission, bringing together scientists, medical specialists, and other healthcare professionals from diverse disciplines who focus on GO2’s areas of impact: healthcare delivery, patient education, policy, and research.
GAC members play a pivotal role in advancing GO2’s mission and achieving its key objectives:
- Increase the number of lung cancers diagnosed early
- Increase the rate of biomarker testing and use of precision medicine
- Increase the impact of community engagement
- Improve quality of life
Current Members of the GO2 Global Advisory Council
- Trever Bivona, MD, PhD; Professor of Medicine; University of California, San Francisco
- Hossein Borghaei, DO, MS; Professor and Chief, Thoracic Oncology; Fox Chase Cancer Center
- Debra S. Dyer, MD, FACR; Professor and Chair, Department of Radiology; National Jewish Health
- Jan M. Eberth, PhD, FACE; Professor and Chair, Health Management and Policy; Drexel University
- Jhanelle E. Gray, MD; Chair, Thoracic Oncology; Moffitt Cancer Center
- Karen Kelly, MD; Chief Executive Officer; International Association for the Study of Lung Cancer
- Christine M. Lovly, MD, PhD, FASCO; Associate Professor of Medicine, Hematology and Oncology; Vanderbilt University Medical Center
- William R. Mayfield, MD, FACS; Medical Director, Lung Cancer Screening and Incidental Nodule Programs; Wellstar Health System
- Peter Mazzone, MD, MPH, FCCP; Head, Thoracic Oncology Program, Pulmonary Department; Cleveland Clinic
- Kathryn F. Mileham, MD, FACP; Co-Lead, Lung Cancer Disease Group and Chief, Thoracic Medical Oncology Section; Atrium Health – Levine Cancer Institute
- Drew Moghanaki, MD, MPH; Professor and Chief of Thoracic Oncology; David Geffen School of Medicine at UCLA
- Ray U. Osarogiagbon, MBBS, FACP; Chief Scientist; Baptist Memorial Healthcare Corporation
- Jamie S. Ostroff, PhD; Chief, Behavioral Sciences Service; Memorial Sloan Kettering Cancer Center
- Luis E. Raez, MD, FACP, FCCP; Chief Scientific Officer & Medical Director; Memorial Cancer Institute
- Natasha Rekhtman, MD, PhD; Attending Pathologist, Thoracic Pathology & Cytopathology; Memorial Sloan Kettering Cancer Center
- Alison Mayer Sachs, MSW, LSW, CSW, OSW-C, FAOSW; Cancer Support Services Consultant
- Pamela Samson, MD, MPHS; Assistant Professor, Department of Radiation Oncology; Washington University in Saint Louis
- Jacob Sands, MD; Physician; Dana-Farber Cancer Institute
- Kerri B. Susko, LISW-CP, OSW-C; Counselor, Center for Integrative Oncology and Survivorship & Director, Cancer Support Community; Prisma Health Cancer Institute
- Jennifer Temel, MD; Professor of Medicine; Massachusetts General Hospital
- Douglas E. Wood, MD, FACS, FRCSEd; The Henry N. Harkins Professor and Chair, Department of Surgery; University of Washington
.